drug therapy in the pediatric patient
TRANSCRIPT
Safe Drug Administration
Administration of drugs during the first year of life can be a challenge due to rapid changes in body size, body composition, and organ function.
Historical Perspective
It was not until the 1970’s that the effects of drug on the neonate and young infant was studied.
Neonate - Absorption
Two major factors affect the absorption of drugspH dependent passive diffusionGastric emptying
Gastric pH
Gastric pH (6-8) is directly related to the presence of amniotic fluid in the stomach.
Postnatally, gastric acid secretory capacity appears after the first 24 to 48 hours and gastric acidity decreases during the first weeks of life.
Adult values are achieved at about 3 months of life.
Gastric pH in premature infant
In the premature infants, gastric pH may remain elevated due to immature acid secretion.
Delayed Absorption
Prolonged emptying is seen in premature infant.
In the neonatal period the emptying rate is variable and prolonged.
Delayed absorption
Delayed absorption may also be a result of diminished pancreatic enzyme function and bile acid secretion.
Absorption from skin
Percutaneous absorption may be drastically increased due to immature epidermis and increased skin hydration.
Absorption from muscle
Absorption from intramuscular site may be unpredictable and decreased due to insufficient blood flow, poor muscle tone, and compromised muscle oxygenation.
Distribution
Distribution of drugs within the body is influenced by the amount and character of plasma proteins, and relative size of fluid, fat and tissue compartments of the body.Total body water Plasma proteins
Total Body Water
85 % in pre-term infant 78% in neonate 60% at 1 year 64 % in childhood (10 to 15 year old) 60% in adults 54% in elderly
Metabolism
Hepatic enzyme activity and plasma / tissue esterase activity are both reduced during the neonatal period.
The enzyme activity increases as the infant ages but can be compromised in cases of severely malnourished infants and children.
Neonate Renal Excretion
Renal ExcretionAt birth, glomerular function is more advanced
that tubular function this persists until about 6 months of age.
This effects the efficiency at which the kidneys eliminate drugs.
This is especially important in the administration of aminoglycosides.
Infant - Absorption
Low acidity in stomach until around 2 years of age.
Gastric emptying still delayed. Percutaneous absorption: continue to be
increased through childhood.
Absorption - IM
Injected drugs are often erratically absorbed because of variability in muscle mass amount children and illness.
IM generally avoided due to pain and possibility of tissue damage.
Absorption - transdermal
May be enhanced in young children because the stratum corneum is thin and the ratio of surface area to weight is much greater than for older children and young adults.
Skin disruptions (abrasions, burns, eczema) increase absorption.
Absorption – transrectal
Transrectal is dependent on placement of the drug within the rectal cavity.Good for drugs such as acetaminophen
(Tylenol).Diazepam in status Epilepticus
Absorption - lungs
Varies less by physiologic parameters and more by reliability of the delivery device.
Beta agonists may be used for asthma, pulmonary surfactant for hyaline membrane disease.
Infant - Distribution
Protein-binding capacity reaches adult values within 10 to 12 months.
Higher doses (mg / kg) of water-soluble drugs are required in younger children due to higher percentage of their body weight in water.
Infant – Hepatic Metabolism
Complete maturation of the liver develops by one year.
Cytochrome P-450 enzyme system in the small bowel and liver are the most important factor in drug metabolism.
Infant – Renal Excretion
Renal elimination depends on plasma protein binding, renal blood flow, GFR and tubular secretion all are altered in the first two years of life.
Drug Dosing
Dosing in children less than 12 years is always of function of age, body weight or both.
When very accurate levels dosing in needed, dose adjustments should be based on plasma drug concentration.
Pharmacokinetics
After one year similar to adults. They metabolize drugs faster than adults
until around age 2 years. Metabolism declines again at puberty. Increase in dosage or reduction in dosing
interval may be needed for drugs that are eliminated by hepatic metabolism.
Dosage Determination
Body surface area calculations are the most accurate.
Mg / kg dosing is most common calculation.
Dosing – amoxicillin
Infants < 3 months or neonates 20 – 30 mg / kg / day in divided doses q
12 hours
Dosing – amoxicillin
po children > 3 months 25 – 50 mg / kg per day in divided doses q
8 hours 24 – 50 mg / kg per day in divided doses q
12 hour
Dosing – amoxicillin
Adults 250 to 500 mg q 8 hours or 500 to 875 q 12 hours (not to exceed 2-3
grams per day)
Weight
Remember 1 pound = 2.2 kg If you are converting a 6 pound 5 ounce
infant you will need to convert 5 ounces to a fraction. (hint 16 ounces in a pound)
OTC Dosing
0-3 months 40 mg q 4 hours 4 to 11 months 80 mg q 4 hours 1-2 years 120 mg q 4 hours 2-3 years 160 mg q 4 hours 4-5 years 240 mg q 4 hours 6-8 years 320 mg q 4 hours 9-10 years 400 mg q 4 hours 11 years 480 mg q 4 hours 12-14 years 640 mg q 4 hours Greater than 14 years 650 mg q 4 hours
How provided?
Elixir 80 mg / 2.5 mL 80 mg / 5 mL 120 mg / 5 mL 160 mg / 5 mL
Drops: 80 mg / 0.8 mL Chewable tabs: 80 mg, 160 mg Tablets: 160 mg, 325 mg, 500 mg, 650 mg
Ibuprofen (Advil or Motrin)
Similar to acetaminophen in its ability to lower fever. FDA has approved it for infants over 6 months of age. One advantage is a longer lasting effect 6 to 8 hours).
Dosing
Children 6 mo – 12 years Antipyretic: 5 – 10 mg / kg every 6 hours Anti-inflammatory: 20 to 40 mg / kg / day
in 3 to 4 divided doses (not to exceed 50 mg / kg / day)
How provided?
Liquid: 100 mg / 5 mL Oral suspension: 100 mg / 5 mL Pediatric drops: 50 mg / 1.25 mL Chewable tablets: 50 mg, 100 mg Capsules: 200 mg Tablets: 100 mg, 200 mg, 300 mg, 400
mg, 600 mg, 800 mg
FDA Alert
Cough and cold medications that contain decongestants, antihistamines, cough suppressants, and expectorants are commonly used in children to provide temporary relief of symptoms of upper respiratory tract infection in children less than 2 years of age.
FDA Alert
During 2004 – 2005 1,519 children were treated in ERs for adverse eventsOverdosing3 deaths in infant younger than 12 months
Cause of death
All three infants had what appeared to be high levels of pseudoephedrine in postmortem blood samplesOne infant had a prescription and an OTC
cough and cold medication at one time.Two infant had OTC cough and cold
medications.
Conclusion
In children less than 2 years of age systematic reviews of controlled trials of OTC cold and could medications have concluded they are not more effective than placebo in reducing acute cough and other symptoms of upper respiratory tract infection.
Recommendations
In 2006 clinical practice guidelines for management of cough advised health care providers to refrain from recommending cough suppressants and other OTC cough mediations for young children.